The global leader in USAN/INN naming, partnering on 76% of USAN and 78% of INN drug name approvals!

550
Healthcare Clients
4055
Total Healthcare Names
118
Antiviral Names
CLIENTNAMECATEGORY
JANSSENadafosbuvirAntiviral
ADAGIOadintrevimabAntiviral
GSKamlivirsenAntiviral
EISAIamolimogene bepiplasmidAntiviral
BRII BIOSCIENCESamubarvimabAntiviral
GSKbeludavimabAntiviral
ATEA PHARMACEUTICALSbemnifosbuvirAntiviral
GSKbepirovirsenAntiviral
JANSSENbersacapavirAntiviral
CHIMERIXbrincidofovirAntiviral
ABBVIEcenicrivirocAntiviral
JANSSENdaplusiranAntiviral
ABBVIEdasabuvirAntiviral
GILEADelipovimabAntiviral
GILEADelunonavirAntiviral
AVIRAGEN THERAPEUTICSenzaplatovirAntiviral
ASSEMBLYfirzacorvirAntiviral
BIOCRYSTgalidesivirAntiviral
ABBVIEglecaprevirAntiviral
SPRING BANKinarigivir soproxilAntiviral
GILEADledipasvirAntiviral
GILEADlenacapavirAntiviral
GREEN CROSSlenvervimabAntiviral
BOEHRINGER INGELHEIMlomtegovimabAntiviral
PFIZERlufotrelvirAntiviral
JANSSENlumicitabineAntiviral
SYNERMOREmazorelvimabAntiviral
PFIZERnirmatrelvirAntiviral
GILEADnivocasanAntiviral
ABBVIEombitasvirAntiviral
ABBVIEpibrentasvirAntiviral
JANSSENpimodivirAntiviral
BAUSCH HEALTHpradefovirAntiviral
GILEADradalbuvirAntiviral
SAREPTA THERAPEUTICSradavirsenAntiviral
GILEADremdesivirAntiviral
JANSSENrilematovirAntiviral
EXEVIRrimteravimabAntiviral
BRII BIOSCIENCESromlusevimabAntiviral
BRII BIOSCIENCESromlusevlimabAntiviral
GILEADrovafovir etalafenamideAntiviral
GILEADselgantolimodAntiviral
ANADYSsetrobuvirAntiviral
JOHNSON & JOHNSONsimeprevirAntiviral
GILEADsofosbuvirAntiviral
GSKsotrovimabAntiviral
VIR BIOTECHNOLOGYsotrovimabAntiviral
BAUSCH HEALTHtaribavirinAntiviral
CONTRAVIR PHARMACEUTICALStenofovir exalidexAntiviral
GILEADteropavimabAntiviral
AVIRAGEN THERAPEUTICSteslexivirAntiviral
JANSSENtomligisiranAntiviral
PFIZERtozinameranAntiviral
BioNTechtozinameranAntiviral
CONTRAVIR PHARMACEUTICALSvalnivudineAntiviral
AVIRAGEN THERAPEUTICSvapendavirAntiviral
ASSEMBLY BIOvebicorvirAntiviral
GILEADvedroprevirAntiviral
GILEADvoxilaprevirAntiviral
SYNERMOREzamerovimabAntiviral